Finance
Fitbit earnings beat, new devices give big boost
Fitbit
- Fitbit
beat on both the top and bottom lines. - The fitness-tracker maker reaffirmed its full-year revenue
guidance of $1.5 billion. - Shares jumped more than 12% ahead of Thursday’s opening bell.
- Watch
Fitbit trade live.
Fitbit
was soaring Thursday, up more than 12% ahead of the opening bell,
after reporting third-quarter results that beat on both the top
and bottom line and reaffirming its full-year revenue guidance.
The fitness-tracker maker earned an adjusted $0.04 a share on
revenue of $394 million, easily beating the $0.01 loss and $381.2
million that was expected by the Bloomberg consensus. Fitbit
reaffirmed its full-year revenue guidance of $1.5 billion, edging
out the $1.49 billion that Wall Street analysts were hoping
for.
“We have been incredibly focused on executing our transition plan
and as a result, saw a return to profitability this quarter, and
are re-affirming our full year revenue guidance of $1.5 billion,”
cofounder and CEO James Park said in the earnings release.
“We succeeded in growing our healthcare business by 26% and
diversifying our revenue to compete in the changing wearables
category and saw sequential growth in both tracker and smartwatch
devices.”
Fitbit said it sold 3.5 million wearable devices during the
quarter, and that the average selling price increased by 3% to
$108. Its Fitbit Versa, Fitbit Charge 3, Fitbit Ace, and
Fitbit Aria 2 — all launced within the past year
— represented 62% of revenue.
“We are now the number two player in the smartwatch space
in the U.S. – a category we just entered with zero share only
fourteen months ago,” Park said.
Fitbit was down 17.16% this year through
Wednesday.
Get the latest Fitbit stock price here.
-
Business7 days ago
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
-
Business6 days ago
Tesla’s new growth plan is centered around mysterious cheaper models
-
Business5 days ago
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
-
Business5 days ago
UK probes Amazon and Microsoft over AI partnerships with Mistral, Anthropic, and Inflection
-
Entertainment3 days ago
Summer Movie Preview: From ‘Alien’ and ‘Furiosa’ to ‘Deadpool and Wolverine’
-
Business6 days ago
Two widow founders launch DayNew, a social platform for people dealing with grief and trauma
-
Entertainment6 days ago
Tesla’s in trouble. Is Elon Musk the problem?
-
Business4 days ago
Petlibro’s new smart refrigerated wet food feeder is what your cat deserves